Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by MASAHIDE YAMAZAKI
Antithrombotic Drug and Its Clinical Indication. Factor Xa Inhibitor. Oral Xa Inhibitor (DX-9065a).
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Related publications
Research and Development Strategy of Antithrombotic Agents: Pharmacology of the Oral Factor Xa-Inhibitor Edoxaban
Folia Pharmacologica Japonica
Pharmacology
Rivaroxaban: An Oral Direct Inhibitor of Factor Xa
American Journal of Health-System Pharmacy
Medicine
Health Policy
Pharmacology
Pharmacy
Ixolaris: A Factor Xa Heparin-Binding Exosite Inhibitor
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Engineering Factor Xa Inhibitor With Multiple Platelet-Binding Sites Facilitates Its Platelet Targeting
Scientific Reports
Multidisciplinary
Effect of Famotidine on the Pharmacokinetics of Apixaban, an Oral Direct Factor Xa Inhibitor
Clinical Pharmacology: Advances and Applications
Pharmacology
Metabolism and Excretion of GCC-4401C, a Factor Xa Inhibitor, in Humans
International Journal of Pharmacokinetics
Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Safety, Pharmacokinetics and Pharmacodynamics of Single Doses of Rivaroxaban – An Oral, Direct Factor Xa Inhibitor – In Elderly Chinese Subjects
Thrombosis and Haemostasis
Hematology
A Phase IV Study of Thromboembolic and Bleeding Events Following Hip and Knee Arthroplasty Using Oral Factor Xa Inhibitor
Journal of Arthroplasty
Orthopedics
Sports Medicine
